PGC-1α4 gene expression is suppressed by the IL-6—MEK—ERK 1/2 MAPK signalling axis and altered by resistance exercise, obesity and muscle injury

J. L. Brown, M. E. Rosa-Caldwell, D. E. Lee, L. A. Brown, R. A. Perry, K. L. Shimkus, T. A. Blackwell, J. D. Fluckey, James Carson, S. Dridi, T. A. Washington, N. P. Greene

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Aim: PGC-1α4 is a novel regulator of muscle hypertrophy; however, there is limited understanding of the regulation of its expression and role in many (patho)physiological conditions. Therefore, our purpose was to elicit signalling mechanisms regulating gene expression of Pgc1α4 and examine its response to (patho)physiological stimuli associated with altered muscle mass. Methods: IL-6 knockout mice and pharmacological experiments in C2C12 myocytes were used to identify regulation of Pgc1α4 transcription. To examine Pgc1α4 gene expression in (patho)physiological conditions, obese and lean Zucker rats with/without resistance exercise (RE), ageing mice and muscle regeneration from injury were examined. Results: In IL-6 knockout mice, Pgc1α4mRNA was ~sevenfold greater than wild type. In C2C12 cells, Pgc1α4mRNA was suppressed ~70% by IL-6. Suppression of Pgc1α4 by IL-6 was prevented by MEK–ERK–MAPK inhibition. RE led to ~260% greater Pgc1α4mRNA content in lean rats. However, obese Zucker rats exhibited ~270% greater Pgc1α4mRNA than lean, sedentary with no further augmentation by RE. No difference was seen in IL-6mRNA or ERK-MAPK phosphorylation in Zucker rats. Aged mice demonstrated ~50% lower Pgc1α4mRNA and ~fivefold greater ERK-MAPK phosphorylation than young despite unchanged Il-6mRNA. During muscle regeneration, Pgc1α4 content is ~30% and IL-6mRNA >threefold of uninjured controls 3 days following injury; at 5 days, Pgc1α4 was >twofold greater in injured mice with no difference in IL-6mRNA. Conclusion: Our findings reveal a novel mechanism suppressing Pgc1α4 gene expression via IL-6–ERK-MAPK and suggest this signalling axis may inhibit Pgc1α4 in some, but not all, (patho)physiological conditions.

Original languageEnglish (US)
Pages (from-to)275-288
Number of pages14
JournalActa Physiologica
Volume220
Issue number2
DOIs
StatePublished - Jun 1 2017
Externally publishedYes

Fingerprint

Interleukin-1
Zucker Rats
Interleukin-6
Obesity
Gene Expression
Muscles
Wounds and Injuries
Knockout Mice
Regeneration
Phosphorylation
Muscle Cells
Hypertrophy
Pharmacology

All Science Journal Classification (ASJC) codes

  • Physiology

Cite this

Brown, J. L., Rosa-Caldwell, M. E., Lee, D. E., Brown, L. A., Perry, R. A., Shimkus, K. L., ... Greene, N. P. (2017). PGC-1α4 gene expression is suppressed by the IL-6—MEK—ERK 1/2 MAPK signalling axis and altered by resistance exercise, obesity and muscle injury. Acta Physiologica, 220(2), 275-288. https://doi.org/10.1111/apha.12826

PGC-1α4 gene expression is suppressed by the IL-6—MEK—ERK 1/2 MAPK signalling axis and altered by resistance exercise, obesity and muscle injury. / Brown, J. L.; Rosa-Caldwell, M. E.; Lee, D. E.; Brown, L. A.; Perry, R. A.; Shimkus, K. L.; Blackwell, T. A.; Fluckey, J. D.; Carson, James; Dridi, S.; Washington, T. A.; Greene, N. P.

In: Acta Physiologica, Vol. 220, No. 2, 01.06.2017, p. 275-288.

Research output: Contribution to journalArticle

Brown, JL, Rosa-Caldwell, ME, Lee, DE, Brown, LA, Perry, RA, Shimkus, KL, Blackwell, TA, Fluckey, JD, Carson, J, Dridi, S, Washington, TA & Greene, NP 2017, 'PGC-1α4 gene expression is suppressed by the IL-6—MEK—ERK 1/2 MAPK signalling axis and altered by resistance exercise, obesity and muscle injury', Acta Physiologica, vol. 220, no. 2, pp. 275-288. https://doi.org/10.1111/apha.12826
Brown, J. L. ; Rosa-Caldwell, M. E. ; Lee, D. E. ; Brown, L. A. ; Perry, R. A. ; Shimkus, K. L. ; Blackwell, T. A. ; Fluckey, J. D. ; Carson, James ; Dridi, S. ; Washington, T. A. ; Greene, N. P. / PGC-1α4 gene expression is suppressed by the IL-6—MEK—ERK 1/2 MAPK signalling axis and altered by resistance exercise, obesity and muscle injury. In: Acta Physiologica. 2017 ; Vol. 220, No. 2. pp. 275-288.
@article{af0aa4f5dcd24519add7e766ef438c7d,
title = "PGC-1α4 gene expression is suppressed by the IL-6—MEK—ERK 1/2 MAPK signalling axis and altered by resistance exercise, obesity and muscle injury",
abstract = "Aim: PGC-1α4 is a novel regulator of muscle hypertrophy; however, there is limited understanding of the regulation of its expression and role in many (patho)physiological conditions. Therefore, our purpose was to elicit signalling mechanisms regulating gene expression of Pgc1α4 and examine its response to (patho)physiological stimuli associated with altered muscle mass. Methods: IL-6 knockout mice and pharmacological experiments in C2C12 myocytes were used to identify regulation of Pgc1α4 transcription. To examine Pgc1α4 gene expression in (patho)physiological conditions, obese and lean Zucker rats with/without resistance exercise (RE), ageing mice and muscle regeneration from injury were examined. Results: In IL-6 knockout mice, Pgc1α4mRNA was ~sevenfold greater than wild type. In C2C12 cells, Pgc1α4mRNA was suppressed ~70{\%} by IL-6. Suppression of Pgc1α4 by IL-6 was prevented by MEK–ERK–MAPK inhibition. RE led to ~260{\%} greater Pgc1α4mRNA content in lean rats. However, obese Zucker rats exhibited ~270{\%} greater Pgc1α4mRNA than lean, sedentary with no further augmentation by RE. No difference was seen in IL-6mRNA or ERK-MAPK phosphorylation in Zucker rats. Aged mice demonstrated ~50{\%} lower Pgc1α4mRNA and ~fivefold greater ERK-MAPK phosphorylation than young despite unchanged Il-6mRNA. During muscle regeneration, Pgc1α4 content is ~30{\%} and IL-6mRNA >threefold of uninjured controls 3 days following injury; at 5 days, Pgc1α4 was >twofold greater in injured mice with no difference in IL-6mRNA. Conclusion: Our findings reveal a novel mechanism suppressing Pgc1α4 gene expression via IL-6–ERK-MAPK and suggest this signalling axis may inhibit Pgc1α4 in some, but not all, (patho)physiological conditions.",
author = "Brown, {J. L.} and Rosa-Caldwell, {M. E.} and Lee, {D. E.} and Brown, {L. A.} and Perry, {R. A.} and Shimkus, {K. L.} and Blackwell, {T. A.} and Fluckey, {J. D.} and James Carson and S. Dridi and Washington, {T. A.} and Greene, {N. P.}",
year = "2017",
month = "6",
day = "1",
doi = "10.1111/apha.12826",
language = "English (US)",
volume = "220",
pages = "275--288",
journal = "Skandinavisches Archiv F{\"u}r Physiologie",
issn = "0370-839X",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - PGC-1α4 gene expression is suppressed by the IL-6—MEK—ERK 1/2 MAPK signalling axis and altered by resistance exercise, obesity and muscle injury

AU - Brown, J. L.

AU - Rosa-Caldwell, M. E.

AU - Lee, D. E.

AU - Brown, L. A.

AU - Perry, R. A.

AU - Shimkus, K. L.

AU - Blackwell, T. A.

AU - Fluckey, J. D.

AU - Carson, James

AU - Dridi, S.

AU - Washington, T. A.

AU - Greene, N. P.

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Aim: PGC-1α4 is a novel regulator of muscle hypertrophy; however, there is limited understanding of the regulation of its expression and role in many (patho)physiological conditions. Therefore, our purpose was to elicit signalling mechanisms regulating gene expression of Pgc1α4 and examine its response to (patho)physiological stimuli associated with altered muscle mass. Methods: IL-6 knockout mice and pharmacological experiments in C2C12 myocytes were used to identify regulation of Pgc1α4 transcription. To examine Pgc1α4 gene expression in (patho)physiological conditions, obese and lean Zucker rats with/without resistance exercise (RE), ageing mice and muscle regeneration from injury were examined. Results: In IL-6 knockout mice, Pgc1α4mRNA was ~sevenfold greater than wild type. In C2C12 cells, Pgc1α4mRNA was suppressed ~70% by IL-6. Suppression of Pgc1α4 by IL-6 was prevented by MEK–ERK–MAPK inhibition. RE led to ~260% greater Pgc1α4mRNA content in lean rats. However, obese Zucker rats exhibited ~270% greater Pgc1α4mRNA than lean, sedentary with no further augmentation by RE. No difference was seen in IL-6mRNA or ERK-MAPK phosphorylation in Zucker rats. Aged mice demonstrated ~50% lower Pgc1α4mRNA and ~fivefold greater ERK-MAPK phosphorylation than young despite unchanged Il-6mRNA. During muscle regeneration, Pgc1α4 content is ~30% and IL-6mRNA >threefold of uninjured controls 3 days following injury; at 5 days, Pgc1α4 was >twofold greater in injured mice with no difference in IL-6mRNA. Conclusion: Our findings reveal a novel mechanism suppressing Pgc1α4 gene expression via IL-6–ERK-MAPK and suggest this signalling axis may inhibit Pgc1α4 in some, but not all, (patho)physiological conditions.

AB - Aim: PGC-1α4 is a novel regulator of muscle hypertrophy; however, there is limited understanding of the regulation of its expression and role in many (patho)physiological conditions. Therefore, our purpose was to elicit signalling mechanisms regulating gene expression of Pgc1α4 and examine its response to (patho)physiological stimuli associated with altered muscle mass. Methods: IL-6 knockout mice and pharmacological experiments in C2C12 myocytes were used to identify regulation of Pgc1α4 transcription. To examine Pgc1α4 gene expression in (patho)physiological conditions, obese and lean Zucker rats with/without resistance exercise (RE), ageing mice and muscle regeneration from injury were examined. Results: In IL-6 knockout mice, Pgc1α4mRNA was ~sevenfold greater than wild type. In C2C12 cells, Pgc1α4mRNA was suppressed ~70% by IL-6. Suppression of Pgc1α4 by IL-6 was prevented by MEK–ERK–MAPK inhibition. RE led to ~260% greater Pgc1α4mRNA content in lean rats. However, obese Zucker rats exhibited ~270% greater Pgc1α4mRNA than lean, sedentary with no further augmentation by RE. No difference was seen in IL-6mRNA or ERK-MAPK phosphorylation in Zucker rats. Aged mice demonstrated ~50% lower Pgc1α4mRNA and ~fivefold greater ERK-MAPK phosphorylation than young despite unchanged Il-6mRNA. During muscle regeneration, Pgc1α4 content is ~30% and IL-6mRNA >threefold of uninjured controls 3 days following injury; at 5 days, Pgc1α4 was >twofold greater in injured mice with no difference in IL-6mRNA. Conclusion: Our findings reveal a novel mechanism suppressing Pgc1α4 gene expression via IL-6–ERK-MAPK and suggest this signalling axis may inhibit Pgc1α4 in some, but not all, (patho)physiological conditions.

UR - http://www.scopus.com/inward/record.url?scp=85005915287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85005915287&partnerID=8YFLogxK

U2 - 10.1111/apha.12826

DO - 10.1111/apha.12826

M3 - Article

VL - 220

SP - 275

EP - 288

JO - Skandinavisches Archiv Für Physiologie

JF - Skandinavisches Archiv Für Physiologie

SN - 0370-839X

IS - 2

ER -